Literature DB >> 29659467

A Standard Push-Pull Protocol for Waste-Free Sampling in the Pediatric Intensive Care Unit.

Clare McBride1, Suzan Miller-Hoover, James A Proudfoot.   

Abstract

Blood sampling is a major source of blood loss in the pediatric intensive care unit (PICU). Blood-sparing sampling techniques such as the push-pull method can significantly reduce sampling-related blood loss and protect patients from anemia and blood transfusions. The push-pull method is supported by research evidence for central venous catheter (CVC) sampling, but research protocols differ and not all CVCs and laboratory tests have been studied. A standard push-pull protocol for the PICU was developed, implemented, and evaluated in this evidence-based practice project. Results show that the protocol can be used safely and reliably as a standard waste-free sampling method in the PICU.

Entities:  

Mesh:

Year:  2018        PMID: 29659467      PMCID: PMC6214664          DOI: 10.1097/NAN.0000000000000279

Source DB:  PubMed          Journal:  J Infus Nurs        ISSN: 1533-1458


  21 in total

1.  Minimization of the preanalytical error in plasma samples for pharmacokinetic analyses and therapeutic drug monitoring--using doxorubicin as an example.

Authors:  Nina E Kontny; Georg Hempel; Joachim Boos; Alan V Boddy; Miriam Krischke
Journal:  Ther Drug Monit       Date:  2011-12       Impact factor: 3.681

2.  Identifying factors to minimize phlebotomy-induced blood loss in the pediatric intensive care unit.

Authors:  Stacey L Valentine; Scot T Bateman
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

3.  Comparison of push-pull versus discard method from central venous catheters for blood testing.

Authors:  K R Holmes
Journal:  J Intraven Nurs       Date:  1998 Sep-Oct

4.  Accuracy of aPTT values drawn from heparinized arterial lines in children.

Authors:  N Richiuso
Journal:  Dimens Crit Care Nurs       Date:  1998 Jan-Feb

5.  A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrations.

Authors:  Jennifer Chen; Sabrina Boodhan; Munira Nanji; Ann Chang; Santhosh Sekharan; Sara Lavoratore; Leonardo R Brandão; Jeffrey M Skolnik; L Lee Dupuis
Journal:  Pharmacotherapy       Date:  2011-08       Impact factor: 4.705

6.  Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer.

Authors:  Jeffrey M Skolnik; Alena Y Zhang; Jeffrey S Barrett; Peter C Adamson
Journal:  Ther Drug Monit       Date:  2010-12       Impact factor: 3.681

7.  A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer.

Authors:  M Cole; L Price; A Parry; S Picton; F Waters; S Marshall; C Goran; A Parnham; H Wastell; M M Reid; A D J Pearson; A V Boddy; G J Veal
Journal:  Pediatr Blood Cancer       Date:  2007-06-15       Impact factor: 3.167

8.  An investigation of the safety of the blood reinfusion step used with tunneled venous access devices in children with cancer.

Authors:  P S Hinds; T Wentz; W Hughes; T Pearson; A Sims; B Mason; M Pratt; B A Austin
Journal:  J Pediatr Oncol Nurs       Date:  1991-10       Impact factor: 1.636

9.  Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.

Authors:  D J Mayo; E P Dimond; W Kramer; M K Horne
Journal:  Oncol Nurs Forum       Date:  1996-05       Impact factor: 2.172

10.  Reinfusion of discard blood from venous access devices.

Authors:  P A Cosca; S Smith; S Chatfield; A Meleason; C A Muir; S Nerantzis; M Petrofsky; S Williams
Journal:  Oncol Nurs Forum       Date:  1998-07       Impact factor: 2.172

View more
  1 in total

1.  Avoidable Blood Loss in Critical Care and Patient Blood Management: Scoping Review of Diagnostic Blood Loss.

Authors:  Philipp Helmer; Sebastian Hottenrott; Andreas Steinisch; Daniel Röder; Jörg Schubert; Udo Steigerwald; Suma Choorapoikayil; Patrick Meybohm
Journal:  J Clin Med       Date:  2022-01-10       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.